Australians suffering from debilitating rare cancers and diseases will experience new hope, thanks to the largest investment in clinical trials in any single round in Australian history.
Through its landmark Medical Research Future Fund, the Morrison Government is investing $55 million to research rare cancers and diseases.
Under the round, the Government is inviting Australia’s best and brightest researchers to apply for grant opportunities. The unprecedented clinical trials activity is aimed at developing new drugs, devices and treatments, and ultimately saving lives.
Of the $55 million:
- $15 million is for research into reproductive cancers, including cancers located in the cervix, uterus, fallopian tubes, endometrium or ovaries in women, and cancer of the testicles in men.
- $5 million is for Childhood Brain Cancer clinical trials, with an aim to double the 10-year survival rate of childhood brain cancer, improve the quality of life of children living with brain cancer, and ultimately find a cure to defeat childhood brain cancer.
- $20 million will address an increasingly significant burden of neurological disorders including Duchenne Muscular Dystrophy, spinal cord injuries and Autism Spectrum Disorders.
- $15 million will address other significant gaps in current research and/or knowledge in rare cancers, rare diseases and areas of unmet medical need.
In Australia, it is estimated more than 40,000 Australians are diagnosed with a rare or less common form of cancer. For many, there is a lack of evidence-based information to inform treatment options and support networks.
While survival rates for high incidence cancers have improved, those for rare cancers have remained relatively static.
People living with a rare disease face significant challenges including diagnostic delays, lack of available treatments and difficulty in finding the appropriate care.